Editorial: Mol Enzyme Drug Targ (e103)
Signal Transduction Pathways in the Clinical Approach: Where are we Going
Author(s): V R Lo Vasco
Research Article: Mol Enzy Drug Targ (11)
Association of HLA Class I and II Antigens with Vitiligo in Egyptian Population
Author(s): Ayman Elgendy, Eslam Alshawadfy, Eman Ali, Nancy Wadea, Karem Khalil, Osama Alkady, Ahmed Elsaidi
Review Article: Mol Enzy Drug Targ (12)
Endothelial Dysfunction An Evolving Target in Diabetic Nephropathy
Author(s): Atul Arya, Surbhi Rana , Sumeet Gupta and Lakhwinder Singh
Research Article: Mol Enzy Drug Targ (13)
Pressure Effect on the Folding of G-Quadruplex DNA Modified with Hexaethylene Glycol
Author(s): Shuntaro Takahashi and Naoki Sugimoto
Commentary: Mol Enzy Drug Targ (14)
ROR1 is an Intriguing Target for Cancer Therapy
Author(s): Ryan Kolb, Paige Kluz and Weizhou Zhang
Editorial: Mol Enzy Drug Targ (e104)
The FAH Fold Meets the Krebs Cycle
Author(s): Pidder Jansen-Duerr, Haymo Pircher, Alexander Weiss
Short Communication: Mol Enzyme Drug Targets (15)
Author(s): Marcia L. Moss
Opinion Article: Mol Enzy Drug Targ (16)
Classification of Enzyme Regulators within Thermodynamic Model of Enzyme Regulation
Author(s): Qinyi Zhao